Circulating semaphorin 4A shows potential for predicting treatment failure in RA September 17, 2023Rheumatoid Arthritis
Tofacitinib + iguratimod offers choice for dual treat-to-target in RA with usual interstitial pneumoniaSeptember 17, 2023Rheumatoid Arthritis
Real-world study supports tocilizumab as first-line biologic in DMARD-IR patients with RASeptember 17, 2023Rheumatoid Arthritis
No effect of initial glucocorticoid bridging on glucocorticoid use over time in RASeptember 17, 2023Rheumatoid Arthritis
No effect of initial glucocorticoid bridging on glucocorticoid use over time in RASeptember 17, 2023Rheumatoid Arthritis
Tapering TNFi raises disease flare likelihood in patients with RA even in those in remissionSeptember 17, 2023Rheumatoid Arthritis
Weight gain and increased BP concerns should not deter low-dose glucocorticoid use in RASeptember 17, 2023Rheumatoid Arthritis
Rheumatology NewsEarly glucocorticoid bridging in RA supported by meta-analysis, but concerns remainSeptember 13, 2023Rheumatoid Arthritis
Rheumatology NewsPrecision blood test for rheumatoid arthritis receives Medicare coverageSeptember 7, 2023Rheumatoid Arthritis
Commentary: Cardiovascular risk, anti-drug antibodies, and prednisolone in RA, September 2023August 31, 2023Rheumatoid Arthritis
Rheumatology NewsACR releases guideline for managing ILD in patients with rheumatic diseaseAugust 30, 2023Lupus & Connective Tissue DiseasesRheumatoid Arthritis
Rheumatology NewsMedicare announces 10 drugs targeted for price cuts in 2026August 30, 2023Business of MedicinePsoriatic ArthritisRheumatoid Arthritis
Rheumatology NewsSlight weight gain, no blood pressure increase with low-dose steroids for RAAugust 29, 2023Rheumatoid Arthritis
Rheumatology NewsRheumatology trials seem vulnerable to unblinding: ReportAugust 28, 2023Rheumatoid ArthritisLupus & Connective Tissue DiseasesPsoriatic ArthritisAnkylosing spondylitis
